Aldurazyme laronidase: Phase I; Phase III ongoing

BRMN and partner Genzyme (GENZ, Cambridge, Mass.) reported in The New England Journal of Medicine results from an open

Read the full 196 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE